5-Bromo-3-iodo-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole, 98%, 100mg

1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine dihydrochloride, 95.0%, 100mg

4-Bromo-1-butanol (contains varying amounts of Tetrahydrofuran)>80.0%(NMR)25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)undecanoic acid, 95%, 5g

1,3-BIS((R)-4-PHENYL-4,5-DIHYDROOXAZOL-2-YL)BENZENE, 95%, 250mg

3-[3-(Trifluoromethyl)phenyl]-1-propanol>98.0%(GC)5g

5-Bromo-1,2,3,4-tetrahydroquinoline, 95.0%, 250mg

4-(tert-Butoxy)-2,5-difluoro-3-methylpyridine, 95+%, 250mg

5-etinilo-dUTP, mínimo 95 %, 100 mM en agua, 10 µl, envase de plástico.

Hyperoside, ROTICHROM® TLC, 25 mg, envase de vidrio

MANT-M3GN2-DNP>98.0%(HPLC)1mg

tert-Butyl 1-formyl-7-azabicyclo[2.2.1]heptane-7-carboxylate, 98%, 500mg

Benzyl (3-hydroxypropyl)carbamate, 95.0%, 1g